<code id='05C4F5AB55'></code><style id='05C4F5AB55'></style>
    • <acronym id='05C4F5AB55'></acronym>
      <center id='05C4F5AB55'><center id='05C4F5AB55'><tfoot id='05C4F5AB55'></tfoot></center><abbr id='05C4F5AB55'><dir id='05C4F5AB55'><tfoot id='05C4F5AB55'></tfoot><noframes id='05C4F5AB55'>

    • <optgroup id='05C4F5AB55'><strike id='05C4F5AB55'><sup id='05C4F5AB55'></sup></strike><code id='05C4F5AB55'></code></optgroup>
        1. <b id='05C4F5AB55'><label id='05C4F5AB55'><select id='05C4F5AB55'><dt id='05C4F5AB55'><span id='05C4F5AB55'></span></dt></select></label></b><u id='05C4F5AB55'></u>
          <i id='05C4F5AB55'><strike id='05C4F5AB55'><tt id='05C4F5AB55'><pre id='05C4F5AB55'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:735

          Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

          advertisement

          For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          FDA approves potent Eli Lilly obesity drug, Zepbound
          FDA approves potent Eli Lilly obesity drug, Zepbound

          DarronCummings/APEliLilly’sblockbusterdrugtirzepatide,soldasMounjarofortype2diabetes,hasbeenclearedt

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Senate panel clears PBM, hopsital reforms

          Sens.RonWydenandMikeCrapopassedanewslateofpharmacybenefitmanagerreformsthroughtheFinanceCommittee.Ke